Cargando…
Thiazolidinediones and Cardiovascular Risk — A Question of Balance
BACKGROUND: Several recent meta-analyses of adverse event data from randomized controlled trials with rosiglitazone reveal a possible association between this thiazolidinedione and an increased risk of ischemic myocardial events. This has led to debate on the overall clinical benefit of glitazone th...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers Ltd.
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822138/ https://www.ncbi.nlm.nih.gov/pubmed/20676274 http://dx.doi.org/10.2174/157340309788970333 |